Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > imagine the questions a big investor would ask..

<< Previous

Bullboard Posts

Next >>

Comment by Alamir1111on Jul 16, 2024 9:08am

183 Views

Post# 36134346

RE:RE:RE:RE:RE:RE:RE:imagine the questions a big investor would ask..

Currently, patients in Canada wait almost two years to access life-saving breakthrough medicines, a year longer than in other developed countries, placing us last in the G7. As Premier Ford takes over as chair of the Council of the Federation, one of his focuses will be doing everything possible to give Canadian patients the same timely access to life-saving treatments as patients in the rest of the world."

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland